Viewing Study NCT06549556



Ignite Creation Date: 2024-10-25 @ 7:52 PM
Last Modification Date: 2024-10-26 @ 3:37 PM
Study NCT ID: NCT06549556
Status: RECRUITING
Last Update Posted: None
First Post: 2024-08-08

Brief Title: The Value of Using Colostrum Supplements on the Physical Performance and Cognitive Function in Healthy Subjects and Type 2 Diabetes
Sponsor: None
Organization: None

Study Overview

Official Title: The Value of Using Colostrum Supplements on the Physical Performance and Cognitive Function in Healthy Subjects and Type 2 Diabetes A Case-management Comparative Study
Status: RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this interventional Randomized clinical is to compare the effect of colostrum pharmaceutical preparation and placebo in a sample of Iraqi participants The main questions to answer are

1 What are the effects of the tested regimens on the level of IL-1 and IL-15
2 What are the effects of the tested regimens on the Fasting Blood glucose
3 What are the effects of the tested regimens on the HbA1C
4 What are the effects of the tested regimens on the Body Mass Index
5 What are the effects of the tested regimens on the Lipid profile
6 What are the effects of the tested regimens on C-reactive protein
7 What are the effects of the tested regimens on Hematological indices
8 What are the effects of the tested regimens on Rate pressure product

Participants will be separated into four groups

1 Group 1 Healthy control 24 Patients will be receiving Placebo Capsule per oral once daily for 60 days
2 Group 2 Healthy control 26 Patients will be receiving Colostrum Capsule 500 mg per oral once daily
3 Group 3 Diabetes Type 2 23 Pateins will be receiving Placebo Capsule per oral once daily for 60 days
4 Group 4 Diabetes Type 2 27 Patients will be receiving Colostrum Capsule 500 mg per oral once daily

Researchers will compare Groups 123 and 4 to observe the effect of the tested treatment regimens on Fasting Blood Glucose HbA1c Lipid profile Rate pressure product C-reactive protein Hematological indices and Body Mass Index and use these measures In special formulas to determine the effect of the tested regimens on physical performance and cognitive function
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None